Projet EviRed à ZEISS
When it comes to managing patients with diabetic retinopathy, Dr. Ramin Tadayoni believes AI and machine learning, in addition to OCT, OCT-A and ultrawide field imaging are here to stay. The development of AI platforms such as EviRed (Intelligent Evaluation of Diabetic Retinopathy), a project Dr. Tadayoni is currently leading in France…
